Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012 (2012), Article ID 721256, 8 pages
http://dx.doi.org/10.1155/2012/721256
Research Article

Beneficial Effects of Aminoguanidine on Skin Flap Survival in Diabetic Rats

1Department of Plastic Reconstructive and Aesthetic Surgery, Inonu University School of Medicine, 44380 Malatya, Turkey
2Department of Plastic, Reconstructive and Aesthetic Surgery, Turgut Ozal Medical Center, Inonu University School of Medicine, 44380 Malatya, Turkey
3Department of Pharmacology, Inonu University School of Medicine, 44380 Malatya, Turkey
4Department of Biochemistry, Inonu University School of Medicine, 44380 Malatya, Turkey
5Department of Pathology, Inonu University School of Medicine, 44380 Malatya, Turkey

Received 12 July 2012; Revised 13 November 2012; Accepted 27 November 2012

Academic Editor: T. S. Kern

Copyright © 2012 Ayse Ozturk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Kennedy and J. W. Baynes, “Non-enzymatic glycosylation and the chronic complications of diabetes: an overview,” Diabetologia, vol. 26, no. 2, pp. 93–98, 1984. View at Google Scholar · View at Scopus
  2. H. Vlassara and M. R. Palace, “Glycoxidation: the menace of diabetes and aging,” Mount Sinai Journal of Medicine, vol. 70, no. 4, pp. 232–241, 2003. View at Google Scholar · View at Scopus
  3. F. Sun, K. Iwaguchi, R. Shudo et al., “Change in tissue concentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes,” Clinical Science, vol. 96, no. 2, pp. 185–190, 1999. View at Google Scholar · View at Scopus
  4. P. J. Thornalley, “Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts,” Archives of Biochemistry and Biophysics, vol. 419, no. 1, pp. 31–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Katz, K. Ekberg, B. L. Johansson, and J. Wahren, “Diminished skin blood flow in type I diabetes: evidence for non-endothelium-dependent dysfunction,” Clinical Science, vol. 101, no. 1, pp. 59–64, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Khan, T. A. Elhadd, S. A. Greene, and J. J. F. Belch, “Impaired skin microvascular function in children, adolescents, and young adults with type I diabetes,” Diabetes Care, vol. 23, no. 2, pp. 215–220, 2000. View at Google Scholar · View at Scopus
  7. M. B. Myers and G. Cherry, “Causes of necrosis in pedicle flaps,” Plastic and Reconstructive Surgery, vol. 42, no. 1, pp. 43–50, 1968. View at Google Scholar · View at Scopus
  8. C. L. Kerrigan, “Skin flap failure: pathophysiology,” Plastic and Reconstructive Surgery, vol. 72, no. 6, pp. 766–774, 1983. View at Google Scholar · View at Scopus
  9. C. Y. Pang, C. R. Forrest, P. C. Neligan, and W. K. Lindsay, “Augmentation of blood flow in delayed random skin flaps in the pig: effect of length of delay period and angiogenesis,” Plastic and Reconstructive Surgery, vol. 78, no. 1, pp. 68–74, 1986. View at Google Scholar · View at Scopus
  10. G. O'Toole, D. MacKenzie, M. Poole, M. F. Buckley, and R. Lindeman, “A review of therapeutic angiogenesis and consideration of its potential applications to plastic and reconstructive surgery,” British Journal of Plastic Surgery, vol. 54, no. 1, pp. 1–7, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. T. P. Misko, W. M. Moore, T. P. Kasten et al., “Selective inhibition of the inducible nitric oxide synthase by aminoguanidine,” European Journal of Pharmacology, vol. 233, no. 1, pp. 119–125, 1993. View at Google Scholar · View at Scopus
  12. K. Sugimoto and S. Yagihashi, “Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats,” Microvascular Research, vol. 53, no. 2, pp. 105–112, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. R. G. Tilton, K. Chang, K. S. Hasan et al., “Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation,” Diabetes, vol. 42, no. 2, pp. 221–232, 1993. View at Google Scholar · View at Scopus
  14. H. Parlakpinar, M. K. Ozer, and A. Acet, “Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats,” Molecular and Cellular Biochemistry, vol. 277, no. 1-2, pp. 137–142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Xu, N. Li, D. Z. Dai, F. Yu, and Y. Dai, “The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidas, ETA, ETB, and MMP9 in the vasculature,” Journal of Cardiovascular Pharmacology, vol. 52, no. 1, pp. 42–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. K. Khouri, M. F. Angel, and L. E. Edstrom, “Standardizing the dorsal rat flap,” Surgical Forum, vol. 37, pp. 590–594, 1986. View at Google Scholar
  17. M. Uchıyama and M. Mıhara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 34, pp. 271–278, 1978. View at Google Scholar
  18. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, pp. 70–77, 1959. View at Google Scholar
  19. Y. Sun, L. W. Oberley, and Y. Li, “A simple method for clinical assay of superoxide dismutase,” Clinical Chemistry, vol. 34, no. 3, pp. 497–500, 1988. View at Google Scholar · View at Scopus
  20. R. M. McFarlane, G. DeYoung, and R. A. Henry, “The design of a pedicle flap in the rat to study necrosis and its prevention,” Plastic and Reconstructive Surgery, vol. 35, pp. 177–182, 1965. View at Google Scholar
  21. K. Z. Kȩdziora-Kornatowska, M. Luciak, J. Błaszczyk, and W. Pawlak, “Effect of aminoguanidine on the generation of superoxide anion and nitric oxide by peripheral blood granulocytes of rats with streptozotocin-induced diabetes,” Clinica Chimica Acta, vol. 278, no. 1, pp. 45–53, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. E. C. Opara, “Oxidative stress, micronutrients, diabetes mellitus and its complications,” Journal of The Royal Society for the Promotion of Health, vol. 122, no. 1, pp. 28–34, 2002. View at Google Scholar · View at Scopus
  23. C. E. Attinger, I. Ducic, P. Cooper, and C. M. Zelen, “The role of intrinsic muscle flaps of the foot for bone coverage in foot and ankle defects in diabetic and nondiabetic patients,” Plastic and Reconstructive Surgery, vol. 110, no. 4, pp. 1047–1054, 2002. View at Google Scholar · View at Scopus
  24. V. Jakus, M. Hrnciarova, J. Carsky et al., “Inhibition of enzymatic proteinglycation and lipid peroxidation by drugs with antioxidant activity,” Life Sciences, vol. 65, pp. 1991–1993, 1999. View at Google Scholar
  25. H. Parlakpinar, M. Koc, A. Polat et al., “Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats,” Urological Research, vol. 32, no. 4, pp. 278–282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Velazquez, P. H. Winocour, P. Kesteven, K. G. M. M. Alberti, and M. F. Laker, “Relation of lipid peroxides to macrovascular disease in Type 2 diabetes,” Diabetic Medicine, vol. 8, no. 8, pp. 752–758, 1991. View at Google Scholar · View at Scopus
  27. S. Moncado, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology and pharmacology,” Pharmacological Reviews, vol. 43, pp. 109–142, 1991. View at Google Scholar
  28. S. A. Lipton, Y. B. Choi, Z. H. Pan et al., “A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds,” Nature, vol. 364, no. 6438, pp. 626–632, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Radi, J. S. Beckman, K. M. Bush, and B. A. Freeman, “Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide,” Journal of Biological Chemistry, vol. 266, no. 7, pp. 4244–4250, 1991. View at Google Scholar · View at Scopus
  30. B. O. Nilsson, “Biological effects of aminoguanidine: an update,” Inflammation Research, vol. 48, no. 10, pp. 509–515, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Hasan, B. J. Heesen, J. A. Corbett et al., “Inhibition of nitric oxide formation by guanidines,” European Journal of Pharmacology, vol. 249, no. 1, pp. 101–106, 1993. View at Publisher · View at Google Scholar · View at Scopus
  32. S. N. Oishi, L. S. Levin, and W. C. Pederson, “Microsurgical management of extremity wounds in diabetics with peripheral vascular disease,” Plastic and Reconstructive Surgery, vol. 92, no. 3, pp. 485–492, 1993. View at Google Scholar · View at Scopus
  33. M. J. Im, P. N. Manson, G. B. Bulkley, and J. E. Hoopes, “Effects of superoxide dismutase and allopurinol on the survival of acute island skin flaps,” Annals of Surgery, vol. 201, no. 3, pp. 357–359, 1985. View at Google Scholar · View at Scopus
  34. M. A. M. Abou-Seif and A. A. Youssef, “Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients,” Clinical Chemistry and Laboratory Medicine, vol. 39, no. 7, pp. 618–623, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Courderot-Masuyer, F. Dalloz, V. Maupoil, and L. Rochette, “Antioxidant properties of aminoguanidine,” Fundamental and Clinical Pharmacology, vol. 13, no. 5, pp. 535–540, 1999. View at Google Scholar · View at Scopus
  36. K. Oikawa, T. Ohbayashi, J. Mimura et al., “Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor,” Biochemical and Biophysical Research Communications, vol. 290, no. 3, pp. 984–987, 2002. View at Publisher · View at Google Scholar · View at Scopus